Avantor, Inc.: Business Overview, Financials & Competitive Analysis
Avantor, Inc. scores 4/10 on the AskCyborg Cyborg Score (Mixed). Revival program execution on digital investments and margin stabilization critical to investor recovery, with 2026 as a pivotal turnaround year. Avantor's $6.55 billion in trailing twelve-month sales was close to revenue five years ago, with revenue declining 3% annually over the last two years and organic revenue averaging 2.3% year-on-year.
What is Avantor, Inc.'s industry? Avantor, Inc. (avantorsciences.com) operates in Life Sciences Tools & Services. AskCyborg classifies Avantor, Inc. under Life Sciences Tools & Services in its company registry.
Avantor is a global provider of mission-critical products and services to customers in biopharma, healthcare, education & government, and advanced technologies & applied materials industries, delivering essential solu...
Cyborg Score thesis
Revival program execution on digital investments and margin stabilization critical to investor recovery, with 2026 as a pivotal...
Read the full analyst-debate transcript →Get the Latest Avantor, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeAvantor, Inc. Overview
Pro stress-test →Avantor is a global provider of mission-critical products and services to customers in biopharma, healthcare, education & government, and advanced technologies & applied materials industries, delivering essential solutions spanning high-purity chemicals and reagents to biologics and cell culture media, lab equipment, consumables and custom manufacturing services. The portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries.
Strategic Profile
Pro stress-test →The company has launched its "Project Revival" initiative designed to sharpen strategic focus and improve execution across the organization, built around five pillars: evolving go-to-market strategy, improving operations, optimizing the portfolio, simplifying processes, and strengthening talent and accountability. Beginning in Q1 2026, Avantor is reorganizing into two new business units: a "product-agnostic channel" and a "channel-agnostic product business."
Competitive Landscape
Pro stress-test →Avantor competes in the life sciences tools and mission-critical products market serving biopharma, healthcare, education, government, and advanced technologies sectors. Key competitors include large diversified life sciences companies like VWR (formerly acquired by Avantor), Thermo Fisher Scientific, and PerkinElmer, along with specialized suppliers across chemical, equipment, and consumables categories.
Industry Context
Avantor, Inc. operates in Life Sciences Tools & Services.
Key facts
Founded: 1904 · Headquarters: Radnor, PA · Revenue: $6.55B